Advancement in the treatment of haemophilia
- 1 October 2018
- journal article
- review article
- Published by Elsevier BV in International Journal of Biological Macromolecules
- Vol. 118, 289-295
- https://doi.org/10.1016/j.ijbiomac.2018.06.084
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Factor VIII inhibitors in hemophilia A: rationale and latest evidenceTherapeutic Advances in Hematology, 2012
- Fc‐fusion proteins: new developments and future perspectivesEMBO Molecular Medicine, 2012
- Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patientsBlood, 2012
- Treatment of hemophilia: a review of current advances and ongoing issuesJournal of Blood Medicine, 2010
- Advancements in gene transfer-based therapy for hemophilia AExpert Review of Hematology, 2009
- Emerging trends in plasma‐free manufacturing of recombinant protein therapeutics expressed in mammalian cellsBiotechnology Journal, 2009
- Characterization of Novel Forms of Coagulation Factor XIaOnline Journal of Public Health Informatics, 2008
- New Approaches in the Management of Inhibitor PatientsActa Haematologica, 2006
- B‐domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma‐derived factor VIII concentrate: a randomized, three‐way crossover studyHaemophilia, 2005
- Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusionBlood, 2003